NORML
AUGUST 22, 2022
Regulators and other concerned parties should seek to provide the public with more comprehensive safety information about the effects of more potent products, and they should continue to ensure that legal products do not get diverted to the youth market. Such actions will ultimately be far more productive than calling for a return to the failures of marijuana prohibition.
The Fresh Toast
AUGUST 22, 2022
Study: Cannabinoids (THC/CBD) Beat Opioids In Managing Chronic Pain. Cannabinoids have a greater benefit-safety profile compared to opioids used to manage chronic neuropathic pain. The post Study: Cannabinoids (THC/CBD) Beat Opioids In Managing Chronic Pain appeared first on The Fresh Toast.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Veriheal
AUGUST 22, 2022
Clinical trials into cannabis’ potential as an opioid replacement are well underway in South Africa. Based on the details of a June 21 press release, the trials—which are taking place in Johannesburg—are the first ethically approved studies exploring the suitability and safety of using cannabis as a substitute for opioid pain relievers. . According to the announcement, Biodata—a subsidiary of Labat Africa—“is the brainchild of Dr.
The Blunt Truth
AUGUST 22, 2022
The District of Columbia legalized cannabis for medicinal purposes in 2010 and began to permit individuals to use the drug recreationally in 2015. Last month, on July 13, 2022, Washington, D.C. Mayor Muriel Bowser signed the “ Cannabis Employment Protections Amendment Act of 2022 ” (D.C. Act 24-483), joining the growing list of jurisdictions prohibiting most employers from taking adverse action (e.g., rejecting job applicants or terminating employees) for off-duty cannabis use.
Speaker: Jonathan Bench, International Cannabis and Securities Business Attorney at Harris Bricken
The U.S. cannabis industry is still in its infancy, even though states began engaging with legalization in one form or another in the late 1990s. Today, many opportunities exist for individuals and businesses that want to engage in the industry. Some want to directly own licensed businesses, while others prefer to keep the industry at an arm’s length and merely profit from it.
CannaMD
AUGUST 22, 2022
Cannabis has been linked to symptom relief involving a number of gastrointestinal disorders, such as inflammatory bowel disease and celiac disease. And now, research suggests that marijuana may also help patients who have been diagnosed with gastroparesis! Gastroparesis is a condition in which the stomach cannot properly empty itself of food in a timely manner. […].
Medical Cannabis Brief brings together the best content for patients and advocates from the widest variety of industry thought leaders.
Canna Law Blog
AUGUST 22, 2022
The U.S. Constitution gives Congress certain enumerated powers ( Article I, Section 8 ), with powers “not delegated to the [federal government] by the Constitution, nor prohibited by it to the states, are reserved to the states respectively, or to the people” ( Tenth Amendment ). While one of the enumerated powers is the regulation of interstate commerce, the federal drug paraphernalia statute, part of the Controlled Substances Act (CSA), renders the sale of drug paraphernalia illega
Leafly
AUGUST 22, 2022
Illinois broke through the chatter with big talk about helping social equity businesses take off. Will the state live up to the hype? The post Will social equity in Illinois live up to the hype? appeared first on Leafly.
Cannabis Law Report
AUGUST 22, 2022
MEDICAL MARIJUANA ACCESS AND PATIENT SAFETY, INC. ISSUES STATEMENT ON PENNSYLVANIA DEPARTMENT OF HEALTH ’ S WITHDRAWAL OF ITS APPEAL TO RECALL CERTAIN VAPORIZED MEDICAL MARIJUANA PRODUCTS. August 22, 2022 (Harrisburg, PA) — Medical Marijuana Access and Patient Safety, Inc. issued the following statement on the Pennsylvania Department of Health’s withdrawal of its appeal in the Supreme Court of Pennsylvania to recall certain vaporized medical marijuana products: On August 17, 2022, the Pen
Leafly
AUGUST 22, 2022
A new, high twist on hard seltzers from 3CHI. These delta-8 seltzers make for an epic crowd-pleaser with 20mg D-8 per can. The post Break out the bubbly with 3CHI’s new delta-8 seltzers appeared first on Leafly.
Cannabis Law Report
AUGUST 22, 2022
Road trips gained popularity during the pandemic because they minimized the possibility of infection through contact. The trend is here to stay, even as the virus recedes and air travel resumes. Travel buffs appreciate the freedom, flexibility, and cost-effectiveness of road trips. You will love them even more if you are a cannabis enthusiast because carrying your stash is relatively easy when you do not have to go through a TSA check and deal with airline rules.
TheAnswerPage
AUGUST 22, 2022
A June 2022 study evaluated medical students’ perception of the use of cannabis-based products for medicinal purposes. Do you think that most medical students believe that cannabis-based products have an acceptable role in medicine? Out of 1,447 medical students surveyed, 526 completed questionnaires for the final analysis. The results indicatd that “The majority of the participants reported that they agree (combined strongly agree/agree/somewhat agree) that ‘cannabis has an ac
Cannabis Life Network
AUGUST 22, 2022
A preliminary study in the Journal of Cannabis Research suggests cannabis users have lower rates of ICU admission for COVID-19. The study says: “Active cannabis users hospitalized with COVID 19 had better clinical outcomes compared with non-users, including decreased need for ICU admission or mechanical ventilation.” Even though the study was retrospective and thus limited with its […].
Expert insights. Personalized for you.
186 
Let's personalize your content